Coastland Capital’s Allergan plc AGN Stock Holding History

Coastland Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-125,000	Closed	-$26.3M	–	119
2016 Q4	$26.3M	Buy	+125,000	New	+$25.9M	0.73%	40

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Coastland Capital's AGN Position: Q1 2017 in Review

Coastland Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 166,250 shares — an estimated $34.9M sold.

Coastland Capital first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $40.7M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Coastland Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Coastland Capital sold 166,250 Allergan plc shares in Q1 2017, an estimated $34.9M.
Coastland Capital first reported a position in Allergan plc in Q1 2014 and held it in 4 quarters.
Coastland Capital's Allergan plc position peaked at $40.7M in Q1 2016.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Coastland Capital's 13F filing for Q1 2017, filed 15 May 2017.